Orion Biotech Opportunities Corp.
ORIAU
NASDAQ Capital Market9.00
USD
- -
- -
CIK
0001847416
ISIN
KYG6780C1252
CUSIP
G6780C125
Return %
Stock
S&P500
1Y
-7.50
18.21
3Y
-10.45
63.29
5Y
-10.45
74.90
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Zuie-Chin Huang
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 645 Fifth Avenue New York City NY United States of America 10022
- IPO Date
- May 11, 2021
- CIK
- 0001847416
- Similar Companies
- Business
- Orion Biotech Opportunities Corp. (Nasdaq: ORIAU) is a blank check company focused on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology and life sciences industries. The company targets North American, European, and Asian healthcare companies developing novel therapies or technologies that drive transformational change; it holds cash in trust from its initial public offering for deployment in such transactions. Founded on February 5, 2021, by co-founders James Huang and Chrystyna Bedrij Stecyk, Orion Biotech Opportunities Corp. is headquartered in New York, NY, with no current operating products or services beyond its special purpose acquisition activities.
Orion Biotech Opportunities Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing July 2, 2021
Orion Biotech Opportunities Corp. Announces Pricing of $200,000,000 Initial Public Offering